| 1 | angiotensin-converting | 2,718 |
| 2 | converting | 1,206 |
| 3 | vsl | 278 |
| 4 | ii-induced | 115 |
| 5 | ii-mediated | 31 |
| 6 | sialyl | 30 |
| 7 | i-converting | 17 |
| 8 | ii-treated | 16 |
| 9 | ubiquitin-conjugating | 13 |
| 10 | ii-stimulated | 11 |
| 11 | tryptophan-degrading | 10 |
| 12 | deubiquitinating | 9 |
| 13 | ivor | 9 |
| 14 | ii-hypertensive | 8 |
| 15 | ii-infused | 8 |
| 16 | angiotension-converting | 7 |
| 17 | educed | 7 |
| 18 | insulin-degrading | 7 |
| 19 | endothelin-converting | 6 |
| 20 | flt3-internal | 6 |
| 21 | i-induced | 6 |
| 22 | 3-internal | 5 |
| 23 | angiotensinconverting | 5 |
| 24 | cortex-lytic | 5 |
| 25 | inositol-requiring | 5 |
| 26 | sec-containing | 5 |
| 27 | tp/dpd | 5 |
| 28 | -converting | 4 |
| 29 | ang-converting | 4 |
| 30 | nedd8-activating | 4 |
| 31 | 11. | 3 |
| 32 | alpha-glucoside | 3 |
| 33 | conversing | 3 |
| 34 | d-vsl | 3 |
| 35 | ixgp | 3 |
| 36 | mrna-editing | 3 |
| 37 | osho | 3 |
| 38 | rigidified | 3 |
| 39 | sulfadoxine\ | 3 |
| 40 | sulindac/inulin/vsl | 3 |
| 41 | 2b15 | 2 |
| 42 | antioxidant-related | 2 |
| 43 | app-cleaving | 2 |
| 44 | aromatizing | 2 |
| 45 | aβ-degrading | 2 |
| 46 | blocker/angiotensin-converting | 2 |
| 47 | et-converting | 2 |
| 48 | gates-glidden | 2 |
| 49 | i-digested | 2 |
| 50 | ii+b | 2 |
| 51 | ii-derived | 2 |
| 52 | interleukin-1beta-converting | 2 |
| 53 | inulin/vsl | 2 |
| 54 | isotopically-labeled | 2 |
| 55 | lectin-directed | 2 |
| 56 | mg2+-dependent | 2 |
| 57 | microparticulate | 2 |
| 58 | mttps5 | 2 |
| 59 | nsp-hydrolysing | 2 |
| 60 | pf0356 | 2 |
| 61 | pisq12-question | 2 |
| 62 | thus-obtained | 2 |
| 63 | virbagen® | 2 |
| 64 | 'proteolytic | 1 |
| 65 | -catabolizing | 1 |
| 66 | -hydrolysing | 1 |
| 67 | -γ-inducible | 1 |
| 68 | /angiotensin-converting | 1 |
| 69 | 1-converting | 1 |
| 70 | 15.5-week-old | 1 |
| 71 | 19.3+/-15.4 | 1 |
| 72 | 2,3-pentanedione-metabolizing | 1 |
| 73 | 2,4-diamino-7-aminoalkoxyquinazolineas | 1 |
| 74 | 34-36-month-old | 1 |
| 75 | 34gy/10 | 1 |
| 76 | 3p25.3-pter | 1 |
| 77 | 4-o-acetylated | 1 |
| 78 | 5-lipoxidase | 1 |
| 79 | 6-plex | 1 |
| 80 | 831-bp | 1 |
| 81 | 8del | 1 |
| 82 | acyl-activating | 1 |
| 83 | adenylating | 1 |
| 84 | adma-degradation | 1 |
| 85 | adma-producing | 1 |
| 86 | agiotensin-coverting | 1 |
| 87 | aii-converting | 1 |
| 88 | amyloid-β-degrading | 1 |
| 89 | anangiotensin-converting | 1 |
| 90 | angiogenesis-converting | 1 |
| 91 | angiontensin-converting | 1 |
| 92 | angiotensin-conventing | 1 |
| 93 | angiotensin-convering | 1 |
| 94 | angiotensin-conversion | 1 |
| 95 | angiotensin-convertng | 1 |
| 96 | angiotensin-coverting | 1 |
| 97 | angiotensin-i-converting | 1 |
| 98 | angiotentsin-converting | 1 |
| 99 | anti-firming | 1 |
| 100 | anticonverting | 1 |
| 101 | antigen-capture | 1 |
| 102 | antisense-oligonucleotide-induced | 1 |
| 103 | arb/angiotensin-converting | 1 |
| 104 | arginine-catabolizing | 1 |
| 105 | bed-capture | 1 |
| 106 | beta-converting | 1 |
| 107 | biomass-degrading | 1 |
| 108 | blockers/angiotensin-converting | 1 |
| 109 | branching-point | 1 |
| 110 | bupropion-metabolising | 1 |
| 111 | c-stereogenic | 1 |
| 112 | carbohydrate-hydrolyzing | 1 |
| 113 | carbohydrose | 1 |
| 114 | catecholamine-metabolizing | 1 |
| 115 | cdc.gov/travel/contentdiseases.aspx | 1 |
| 116 | chemiluminescnet | 1 |
| 117 | cis-interacting | 1 |
| 118 | cm-inactivating | 1 |
| 119 | co-ligated | 1 |
| 120 | ct.gov | 1 |
| 121 | ctgca | 1 |
| 122 | de-clustered | 1 |
| 123 | dehydrogenase/gapdh | 1 |
| 124 | dehydroquinase | 1 |
| 125 | deubiqutinating | 1 |
| 126 | digitonin-activated | 1 |
| 127 | disease.angiotensin-converting | 1 |
| 128 | dna-degrading | 1 |
| 129 | donor-free | 1 |
| 130 | drug-caused | 1 |
| 131 | e2-ub-conjugating | 1 |
| 132 | elastase-like | 1 |
| 133 | endoacting | 1 |
| 134 | environment-resistant | 1 |
| 135 | erectolytic | 1 |
| 136 | ethylene-forming | 1 |
| 137 | extralysosomal | 1 |
| 138 | fe-catalyzed | 1 |
| 139 | flavoprotein-dependent | 1 |
| 140 | fluorescence-linked | 1 |
| 141 | glucocorticoid-activating | 1 |
| 142 | glucocorticoid-generating | 1 |
| 143 | glutamate-producer | 1 |
| 144 | glutamylation-performing | 1 |
| 145 | glutathione-degrading | 1 |
| 146 | glycolytic/oxidative | 1 |
| 147 | hematopoietically-important | 1 |
| 148 | hemi-labeled | 1 |
| 149 | hemoprotein-containing | 1 |
| 150 | histamine-degrading | 1 |
| 151 | hocl-producing | 1 |
| 152 | homo-octameric | 1 |
| 153 | hydroperoxidase | 1 |
| 154 | i-inhibitor | 1 |
| 155 | i-inhibitors | 1 |
| 156 | i-light | 1 |
| 157 | ifnα-inducible | 1 |
| 158 | ii-activated | 1 |
| 159 | ii-overproducing | 1 |
| 160 | ii-pretreated | 1 |
| 161 | ii/bradykinin | 1 |
| 162 | ii/multicore | 1 |
| 163 | iihas | 1 |
| 164 | il-1b-converting | 1 |
| 165 | induceable | 1 |
| 166 | intrafamily/phylogenetic | 1 |
| 167 | ischemia-reperfused | 1 |
| 168 | ischemia.male | 1 |
| 169 | isobm | 1 |
| 170 | kornberg | 1 |
| 171 | l-digested | 1 |
| 172 | lactonizing | 1 |
| 173 | lewis-acid-catalyzed | 1 |
| 174 | lignin-degrading | 1 |
| 175 | lipogenic-related | 1 |
| 176 | lleras | 1 |
| 177 | low-estrogen-replaced | 1 |
| 178 | luciferase-like | 1 |
| 179 | machos | 1 |
| 180 | microsome-specific | 1 |
| 181 | moxr | 1 |
| 182 | mtps5 | 1 |
| 183 | n-nitrosodimethylamine-treated | 1 |
| 184 | nad-metabolizing | 1 |
| 185 | nanogerians | 1 |
| 186 | neoepitope-based | 1 |
| 187 | neuropeptide-degrading | 1 |
| 188 | nicotine-metabolising | 1 |
| 189 | non-angiotensin-converting | 1 |
| 190 | non-dysjunction | 1 |
| 191 | non-sialylated | 1 |
| 192 | p.q1651x | 1 |
| 193 | p.r966w | 1 |
| 194 | p.w1666x | 1 |
| 195 | pe-generating | 1 |
| 196 | pepsin-pancreatin | 1 |
| 197 | phers | 1 |
| 198 | phosphofructokinase-1 | 1 |
| 199 | phosphohydrolitic | 1 |
| 200 | polysaccharide-degrading | 1 |
| 201 | prdii-prdi | 1 |
| 202 | pre-matured | 1 |
| 203 | prenyltransferase | 1 |
| 204 | pse-2 | 1 |
| 205 | pseudo-gem-bridged | 1 |
| 206 | rabggtase | 1 |
| 207 | reamplifying | 1 |
| 208 | receptor-destroying | 1 |
| 209 | retinoid-degrading | 1 |
| 210 | risk. | 1 |
| 211 | routledgei | 1 |
| 212 | rps16 | 1 |
| 213 | ser/thr-specific | 1 |
| 214 | serum-angiotensin-converting | 1 |
| 215 | side-chain-cleavage | 1 |
| 216 | spf10-pcr | 1 |
| 217 | stress.angiotensin-converting | 1 |
| 218 | sulfataricus | 1 |
| 219 | sulfate-degrading | 1 |
| 220 | sumo-conjugating | 1 |
| 221 | sureselect | 1 |
| 222 | thermo-active | 1 |
| 223 | thermophilic-mesophilic | 1 |
| 224 | tnf-alpha-converting | 1 |
| 225 | tnfalpha-converting | 1 |
| 226 | trehalose-degrading | 1 |
| 227 | twenty-male-four-month-old | 1 |
| 228 | ubiquitin-modifying | 1 |
| 229 | ubiquituous | 1 |
| 230 | val-containing | 1 |
| 231 | β-1,3-glucan-degrading | 1 |
| 232 | ⅱ-induced | 1 |
| 1 | 'proteolytic | 1 |
| 2 | -catabolizing | 1 |
| 3 | -converting | 4 |
| 4 | -hydrolysing | 1 |
| 5 | -γ-inducible | 1 |
| 6 | /angiotensin-converting | 1 |
| 7 | 1-converting | 1 |
| 8 | 11. | 3 |
| 9 | 15.5-week-old | 1 |
| 10 | 19.3+/-15.4 | 1 |
| 11 | 2,3-pentanedione-metabolizing | 1 |
| 12 | 2,4-diamino-7-aminoalkoxyquinazolineas | 1 |
| 13 | 2b15 | 2 |
| 14 | 3-internal | 5 |
| 15 | 34-36-month-old | 1 |
| 16 | 34gy/10 | 1 |
| 17 | 3p25.3-pter | 1 |
| 18 | 4-o-acetylated | 1 |
| 19 | 5-lipoxidase | 1 |
| 20 | 6-plex | 1 |
| 21 | 831-bp | 1 |
| 22 | 8del | 1 |
| 23 | acyl-activating | 1 |
| 24 | adenylating | 1 |
| 25 | adma-degradation | 1 |
| 26 | adma-producing | 1 |
| 27 | agiotensin-coverting | 1 |
| 28 | aii-converting | 1 |
| 29 | alpha-glucoside | 3 |
| 30 | amyloid-β-degrading | 1 |
| 31 | anangiotensin-converting | 1 |
| 32 | ang-converting | 4 |
| 33 | angiogenesis-converting | 1 |
| 34 | angiontensin-converting | 1 |
| 35 | angiotensin-conventing | 1 |
| 36 | angiotensin-convering | 1 |
| 37 | angiotensin-conversion | 1 |
| 38 | angiotensin-converting | 2,718 |
| 39 | angiotensin-convertng | 1 |
| 40 | angiotensin-coverting | 1 |
| 41 | angiotensin-i-converting | 1 |
| 42 | angiotensinconverting | 5 |
| 43 | angiotension-converting | 7 |
| 44 | angiotentsin-converting | 1 |
| 45 | anti-firming | 1 |
| 46 | anticonverting | 1 |
| 47 | antigen-capture | 1 |
| 48 | antioxidant-related | 2 |
| 49 | antisense-oligonucleotide-induced | 1 |
| 50 | app-cleaving | 2 |
| 51 | arb/angiotensin-converting | 1 |
| 52 | arginine-catabolizing | 1 |
| 53 | aromatizing | 2 |
| 54 | aβ-degrading | 2 |
| 55 | bed-capture | 1 |
| 56 | beta-converting | 1 |
| 57 | biomass-degrading | 1 |
| 58 | blocker/angiotensin-converting | 2 |
| 59 | blockers/angiotensin-converting | 1 |
| 60 | branching-point | 1 |
| 61 | bupropion-metabolising | 1 |
| 62 | c-stereogenic | 1 |
| 63 | carbohydrate-hydrolyzing | 1 |
| 64 | carbohydrose | 1 |
| 65 | catecholamine-metabolizing | 1 |
| 66 | cdc.gov/travel/contentdiseases.aspx | 1 |
| 67 | chemiluminescnet | 1 |
| 68 | cis-interacting | 1 |
| 69 | cm-inactivating | 1 |
| 70 | co-ligated | 1 |
| 71 | conversing | 3 |
| 72 | converting | 1,206 |
| 73 | cortex-lytic | 5 |
| 74 | ct.gov | 1 |
| 75 | ctgca | 1 |
| 76 | d-vsl | 3 |
| 77 | de-clustered | 1 |
| 78 | dehydrogenase/gapdh | 1 |
| 79 | dehydroquinase | 1 |
| 80 | deubiquitinating | 9 |
| 81 | deubiqutinating | 1 |
| 82 | digitonin-activated | 1 |
| 83 | disease.angiotensin-converting | 1 |
| 84 | dna-degrading | 1 |
| 85 | donor-free | 1 |
| 86 | drug-caused | 1 |
| 87 | e2-ub-conjugating | 1 |
| 88 | educed | 7 |
| 89 | elastase-like | 1 |
| 90 | endoacting | 1 |
| 91 | endothelin-converting | 6 |
| 92 | environment-resistant | 1 |
| 93 | erectolytic | 1 |
| 94 | et-converting | 2 |
| 95 | ethylene-forming | 1 |
| 96 | extralysosomal | 1 |
| 97 | fe-catalyzed | 1 |
| 98 | flavoprotein-dependent | 1 |
| 99 | flt3-internal | 6 |
| 100 | fluorescence-linked | 1 |
| 101 | gates-glidden | 2 |
| 102 | glucocorticoid-activating | 1 |
| 103 | glucocorticoid-generating | 1 |
| 104 | glutamate-producer | 1 |
| 105 | glutamylation-performing | 1 |
| 106 | glutathione-degrading | 1 |
| 107 | glycolytic/oxidative | 1 |
| 108 | hematopoietically-important | 1 |
| 109 | hemi-labeled | 1 |
| 110 | hemoprotein-containing | 1 |
| 111 | histamine-degrading | 1 |
| 112 | hocl-producing | 1 |
| 113 | homo-octameric | 1 |
| 114 | hydroperoxidase | 1 |
| 115 | i-converting | 17 |
| 116 | i-digested | 2 |
| 117 | i-induced | 6 |
| 118 | i-inhibitor | 1 |
| 119 | i-inhibitors | 1 |
| 120 | i-light | 1 |
| 121 | ifnα-inducible | 1 |
| 122 | ii+b | 2 |
| 123 | ii-activated | 1 |
| 124 | ii-derived | 2 |
| 125 | ii-hypertensive | 8 |
| 126 | ii-induced | 115 |
| 127 | ii-infused | 8 |
| 128 | ii-mediated | 31 |
| 129 | ii-overproducing | 1 |
| 130 | ii-pretreated | 1 |
| 131 | ii-stimulated | 11 |
| 132 | ii-treated | 16 |
| 133 | ii/bradykinin | 1 |
| 134 | ii/multicore | 1 |
| 135 | iihas | 1 |
| 136 | il-1b-converting | 1 |
| 137 | induceable | 1 |
| 138 | inositol-requiring | 5 |
| 139 | insulin-degrading | 7 |
| 140 | interleukin-1beta-converting | 2 |
| 141 | intrafamily/phylogenetic | 1 |
| 142 | inulin/vsl | 2 |
| 143 | ischemia-reperfused | 1 |
| 144 | ischemia.male | 1 |
| 145 | isobm | 1 |
| 146 | isotopically-labeled | 2 |
| 147 | ivor | 9 |
| 148 | ixgp | 3 |
| 149 | kornberg | 1 |
| 150 | l-digested | 1 |
| 151 | lactonizing | 1 |
| 152 | lectin-directed | 2 |
| 153 | lewis-acid-catalyzed | 1 |
| 154 | lignin-degrading | 1 |
| 155 | lipogenic-related | 1 |
| 156 | lleras | 1 |
| 157 | low-estrogen-replaced | 1 |
| 158 | luciferase-like | 1 |
| 159 | machos | 1 |
| 160 | mg2+-dependent | 2 |
| 161 | microparticulate | 2 |
| 162 | microsome-specific | 1 |
| 163 | moxr | 1 |
| 164 | mrna-editing | 3 |
| 165 | mtps5 | 1 |
| 166 | mttps5 | 2 |
| 167 | n-nitrosodimethylamine-treated | 1 |
| 168 | nad-metabolizing | 1 |
| 169 | nanogerians | 1 |
| 170 | nedd8-activating | 4 |
| 171 | neoepitope-based | 1 |
| 172 | neuropeptide-degrading | 1 |
| 173 | nicotine-metabolising | 1 |
| 174 | non-angiotensin-converting | 1 |
| 175 | non-dysjunction | 1 |
| 176 | non-sialylated | 1 |
| 177 | nsp-hydrolysing | 2 |
| 178 | osho | 3 |
| 179 | p.q1651x | 1 |
| 180 | p.r966w | 1 |
| 181 | p.w1666x | 1 |
| 182 | pe-generating | 1 |
| 183 | pepsin-pancreatin | 1 |
| 184 | pf0356 | 2 |
| 185 | phers | 1 |
| 186 | phosphofructokinase-1 | 1 |
| 187 | phosphohydrolitic | 1 |
| 188 | pisq12-question | 2 |
| 189 | polysaccharide-degrading | 1 |
| 190 | prdii-prdi | 1 |
| 191 | pre-matured | 1 |
| 192 | prenyltransferase | 1 |
| 193 | pse-2 | 1 |
| 194 | pseudo-gem-bridged | 1 |
| 195 | rabggtase | 1 |
| 196 | reamplifying | 1 |
| 197 | receptor-destroying | 1 |
| 198 | retinoid-degrading | 1 |
| 199 | rigidified | 3 |
| 200 | risk. | 1 |
| 201 | routledgei | 1 |
| 202 | rps16 | 1 |
| 203 | sec-containing | 5 |
| 204 | ser/thr-specific | 1 |
| 205 | serum-angiotensin-converting | 1 |
| 206 | sialyl | 30 |
| 207 | side-chain-cleavage | 1 |
| 208 | spf10-pcr | 1 |
| 209 | stress.angiotensin-converting | 1 |
| 210 | sulfadoxine\ | 3 |
| 211 | sulfataricus | 1 |
| 212 | sulfate-degrading | 1 |
| 213 | sulindac/inulin/vsl | 3 |
| 214 | sumo-conjugating | 1 |
| 215 | sureselect | 1 |
| 216 | thermo-active | 1 |
| 217 | thermophilic-mesophilic | 1 |
| 218 | thus-obtained | 2 |
| 219 | tnf-alpha-converting | 1 |
| 220 | tnfalpha-converting | 1 |
| 221 | tp/dpd | 5 |
| 222 | trehalose-degrading | 1 |
| 223 | tryptophan-degrading | 10 |
| 224 | twenty-male-four-month-old | 1 |
| 225 | ubiquitin-conjugating | 13 |
| 226 | ubiquitin-modifying | 1 |
| 227 | ubiquituous | 1 |
| 228 | val-containing | 1 |
| 229 | virbagen® | 2 |
| 230 | vsl | 278 |
| 231 | β-1,3-glucan-degrading | 1 |
| 232 | ⅱ-induced | 1 |
| 1 | 11. | 3 |
| 2 | risk. | 1 |
| 3 | 34gy/10 | 1 |
| 4 | phosphofructokinase-1 | 1 |
| 5 | pse-2 | 1 |
| 6 | 19.3+/-15.4 | 1 |
| 7 | 2b15 | 2 |
| 8 | mtps5 | 1 |
| 9 | mttps5 | 2 |
| 10 | rps16 | 1 |
| 11 | pf0356 | 2 |
| 12 | sulfadoxine\ | 3 |
| 13 | ctgca | 1 |
| 14 | ii+b | 2 |
| 15 | microsome-specific | 1 |
| 16 | ser/thr-specific | 1 |
| 17 | thermophilic-mesophilic | 1 |
| 18 | c-stereogenic | 1 |
| 19 | homo-octameric | 1 |
| 20 | intrafamily/phylogenetic | 1 |
| 21 | phosphohydrolitic | 1 |
| 22 | cortex-lytic | 5 |
| 23 | 'proteolytic | 1 |
| 24 | erectolytic | 1 |
| 25 | low-estrogen-replaced | 1 |
| 26 | educed | 7 |
| 27 | antisense-oligonucleotide-induced | 1 |
| 28 | i-induced | 6 |
| 29 | ii-induced | 115 |
| 30 | ⅱ-induced | 1 |
| 31 | pseudo-gem-bridged | 1 |
| 32 | rigidified | 3 |
| 33 | fluorescence-linked | 1 |
| 34 | hemi-labeled | 1 |
| 35 | isotopically-labeled | 2 |
| 36 | thus-obtained | 2 |
| 37 | de-clustered | 1 |
| 38 | pre-matured | 1 |
| 39 | neoepitope-based | 1 |
| 40 | drug-caused | 1 |
| 41 | ii-infused | 8 |
| 42 | ischemia-reperfused | 1 |
| 43 | n-nitrosodimethylamine-treated | 1 |
| 44 | ii-treated | 16 |
| 45 | ii-pretreated | 1 |
| 46 | co-ligated | 1 |
| 47 | ii-mediated | 31 |
| 48 | lipogenic-related | 1 |
| 49 | antioxidant-related | 2 |
| 50 | ii-stimulated | 11 |
| 51 | non-sialylated | 1 |
| 52 | 4-o-acetylated | 1 |
| 53 | ii-activated | 1 |
| 54 | digitonin-activated | 1 |
| 55 | lectin-directed | 2 |
| 56 | i-digested | 2 |
| 57 | l-digested | 1 |
| 58 | ii-derived | 2 |
| 59 | lewis-acid-catalyzed | 1 |
| 60 | fe-catalyzed | 1 |
| 61 | 34-36-month-old | 1 |
| 62 | twenty-male-four-month-old | 1 |
| 63 | 15.5-week-old | 1 |
| 64 | tp/dpd | 5 |
| 65 | alpha-glucoside | 3 |
| 66 | donor-free | 1 |
| 67 | side-chain-cleavage | 1 |
| 68 | luciferase-like | 1 |
| 69 | elastase-like | 1 |
| 70 | ischemia.male | 1 |
| 71 | induceable | 1 |
| 72 | ifnα-inducible | 1 |
| 73 | -γ-inducible | 1 |
| 74 | ii/multicore | 1 |
| 75 | bed-capture | 1 |
| 76 | antigen-capture | 1 |
| 77 | 5-lipoxidase | 1 |
| 78 | hydroperoxidase | 1 |
| 79 | dehydroquinase | 1 |
| 80 | prenyltransferase | 1 |
| 81 | rabggtase | 1 |
| 82 | carbohydrose | 1 |
| 83 | microparticulate | 2 |
| 84 | ii-hypertensive | 8 |
| 85 | glycolytic/oxidative | 1 |
| 86 | thermo-active | 1 |
| 87 | adma-producing | 1 |
| 88 | hocl-producing | 1 |
| 89 | ii-overproducing | 1 |
| 90 | dna-degrading | 1 |
| 91 | retinoid-degrading | 1 |
| 92 | polysaccharide-degrading | 1 |
| 93 | neuropeptide-degrading | 1 |
| 94 | histamine-degrading | 1 |
| 95 | glutathione-degrading | 1 |
| 96 | trehalose-degrading | 1 |
| 97 | sulfate-degrading | 1 |
| 98 | β-1,3-glucan-degrading | 1 |
| 99 | tryptophan-degrading | 10 |
| 100 | insulin-degrading | 7 |
| 101 | lignin-degrading | 1 |
| 102 | biomass-degrading | 1 |
| 103 | amyloid-β-degrading | 1 |
| 104 | aβ-degrading | 2 |
| 105 | anti-firming | 1 |
| 106 | ethylene-forming | 1 |
| 107 | glutamylation-performing | 1 |
| 108 | sec-containing | 5 |
| 109 | val-containing | 1 |
| 110 | hemoprotein-containing | 1 |
| 111 | angiotensin-convering | 1 |
| 112 | inositol-requiring | 5 |
| 113 | nicotine-metabolising | 1 |
| 114 | bupropion-metabolising | 1 |
| 115 | conversing | 3 |
| 116 | -hydrolysing | 1 |
| 117 | nsp-hydrolysing | 2 |
| 118 | e2-ub-conjugating | 1 |
| 119 | ubiquitin-conjugating | 13 |
| 120 | sumo-conjugating | 1 |
| 121 | adenylating | 1 |
| 122 | deubiquitinating | 9 |
| 123 | deubiqutinating | 1 |
| 124 | glucocorticoid-generating | 1 |
| 125 | pe-generating | 1 |
| 126 | nedd8-activating | 4 |
| 127 | glucocorticoid-activating | 1 |
| 128 | acyl-activating | 1 |
| 129 | cm-inactivating | 1 |
| 130 | endoacting | 1 |
| 131 | cis-interacting | 1 |
| 132 | mrna-editing | 3 |
| 133 | angiotensin-conventing | 1 |
| 134 | converting | 1,206 |
| 135 | -converting | 4 |
| 136 | 1-converting | 1 |
| 137 | tnf-alpha-converting | 1 |
| 138 | tnfalpha-converting | 1 |
| 139 | beta-converting | 1 |
| 140 | interleukin-1beta-converting | 2 |
| 141 | il-1b-converting | 1 |
| 142 | ang-converting | 4 |
| 143 | i-converting | 17 |
| 144 | angiotensin-i-converting | 1 |
| 145 | aii-converting | 1 |
| 146 | endothelin-converting | 6 |
| 147 | angiontensin-converting | 1 |
| 148 | angiotensin-converting | 2,718 |
| 149 | serum-angiotensin-converting | 1 |
| 150 | non-angiotensin-converting | 1 |
| 151 | disease.angiotensin-converting | 1 |
| 152 | stress.angiotensin-converting | 1 |
| 153 | /angiotensin-converting | 1 |
| 154 | arb/angiotensin-converting | 1 |
| 155 | blocker/angiotensin-converting | 2 |
| 156 | blockers/angiotensin-converting | 1 |
| 157 | anangiotensin-converting | 1 |
| 158 | angiotentsin-converting | 1 |
| 159 | angiotension-converting | 7 |
| 160 | angiogenesis-converting | 1 |
| 161 | et-converting | 2 |
| 162 | anticonverting | 1 |
| 163 | angiotensinconverting | 5 |
| 164 | agiotensin-coverting | 1 |
| 165 | angiotensin-coverting | 1 |
| 166 | app-cleaving | 2 |
| 167 | ubiquitin-modifying | 1 |
| 168 | reamplifying | 1 |
| 169 | receptor-destroying | 1 |
| 170 | -catabolizing | 1 |
| 171 | arginine-catabolizing | 1 |
| 172 | nad-metabolizing | 1 |
| 173 | catecholamine-metabolizing | 1 |
| 174 | 2,3-pentanedione-metabolizing | 1 |
| 175 | lactonizing | 1 |
| 176 | aromatizing | 2 |
| 177 | carbohydrate-hydrolyzing | 1 |
| 178 | angiotensin-convertng | 1 |
| 179 | kornberg | 1 |
| 180 | dehydrogenase/gapdh | 1 |
| 181 | prdii-prdi | 1 |
| 182 | routledgei | 1 |
| 183 | extralysosomal | 1 |
| 184 | 3-internal | 5 |
| 185 | flt3-internal | 6 |
| 186 | 8del | 1 |
| 187 | vsl | 278 |
| 188 | d-vsl | 3 |
| 189 | inulin/vsl | 2 |
| 190 | sulindac/inulin/vsl | 3 |
| 191 | sialyl | 30 |
| 192 | isobm | 1 |
| 193 | gates-glidden | 2 |
| 194 | ii/bradykinin | 1 |
| 195 | pepsin-pancreatin | 1 |
| 196 | angiotensin-conversion | 1 |
| 197 | adma-degradation | 1 |
| 198 | non-dysjunction | 1 |
| 199 | pisq12-question | 2 |
| 200 | osho | 3 |
| 201 | 831-bp | 1 |
| 202 | ixgp | 3 |
| 203 | spf10-pcr | 1 |
| 204 | glutamate-producer | 1 |
| 205 | 3p25.3-pter | 1 |
| 206 | i-inhibitor | 1 |
| 207 | ivor | 9 |
| 208 | moxr | 1 |
| 209 | 2,4-diamino-7-aminoalkoxyquinazolineas | 1 |
| 210 | iihas | 1 |
| 211 | lleras | 1 |
| 212 | nanogerians | 1 |
| 213 | machos | 1 |
| 214 | phers | 1 |
| 215 | i-inhibitors | 1 |
| 216 | sulfataricus | 1 |
| 217 | ubiquituous | 1 |
| 218 | sureselect | 1 |
| 219 | chemiluminescnet | 1 |
| 220 | i-light | 1 |
| 221 | hematopoietically-important | 1 |
| 222 | environment-resistant | 1 |
| 223 | mg2+-dependent | 2 |
| 224 | flavoprotein-dependent | 1 |
| 225 | branching-point | 1 |
| 226 | ct.gov | 1 |
| 227 | p.r966w | 1 |
| 228 | p.q1651x | 1 |
| 229 | p.w1666x | 1 |
| 230 | 6-plex | 1 |
| 231 | cdc.gov/travel/contentdiseases.aspx | 1 |
| 232 | virbagen® | 2 |